scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "VACCINES"

1 - 10 of 554,893 results for
 "VACCINES"
Results per page:

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).

Publication Type: Academic Journal

Source(s): Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-14. Date of Electronic Publication: 2021 Nov 02.

Abstract: Streptococcus pneumoniae and influenza viruses are associated with significant morbidity and mortality in older adults. Concomitant vaccination against these agents reduces hospitalization and mortality rates. This phase 3 trial evaluated safety, toler...

View details

Immune response against viral infections and nucleic acid-based vaccines.

Publication Type: Editorial & Opinion

Source(s): Scandinavian journal of immunology [Scand J Immunol] 2022 Dec; Vol. 96 (6), pp. e13221. Date of Electronic Publication: 2022 Oct 13.

Authors:
View details

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China.

Publication Type: Academic Journal

Source(s): Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2043025. Date of Electronic Publication: 2022 Mar 23.

Authors:

Abstract: Given increased global concern about vaccine hesitancy, this study estimates coverage of mandatory vs non-mandatory vaccines in children, and assesses whether vaccine hesitancy among young parents relates to their child's eventual vaccination status in...

View details

The burden of selected vaccine-preventable diseases on the secondary care health system in England: Results from a five-year administrative healthcare dataset.

Publication Type: Academic Journal

Source(s): Vaccine [Vaccine] 2022 Nov 15; Vol. 40 (48), pp. 6939-6946. Date of Electronic Publication: 2022 Oct 21.

Abstract: Objectives: This study examined healthcare resource use (HCRU) for selected vaccine-preventable diseases (VPD) in secondary care in England.Methods: The hospital episode statistics (HES) dataset covering all secondary care interactions within the Engli...

View details

Expanded table: Some vaccines for adults.

Publication Type: Academic Journal

Source(s): The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2022 Oct 17; Vol. 64 (1661), pp. e170-e173. Date of Electronic Publication: 2022 Oct 17.

View details

Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.

Publication Type: Academic Journal

Source(s): Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 2510-2519.

Authors:

Abstract: Three inactivated enterovirus A71 (EV-A71) vaccines have been widely vaccinated among children in the targeted age group in mainland China since mid-2016. However, comprehensive virological surveillance of hand, foot and mouth disease (HFMD) over multi...

View details

Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy.

Publication Type: Academic Journal

Source(s): Expert review of vaccines [Expert Rev Vaccines] 2022 Dec; Vol. 21 (12), pp. 1819-1830. Date of Electronic Publication: 2022 Nov 27.

Abstract: Introduction: Two vaccine formulations are available to prevent diphtheria, tetanus, pertussis, and poliomyelitis: the pediatric full-dose (DTaP-IPV) and the reduced dose formulation (dTap-IPV). Different immunization schedules are internationally reco...

View details

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia.

Publication Type: Academic Journal

Source(s): Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2066426. Date of Electronic Publication: 2022 Apr 21.

Abstract: Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months. In addition to inadequate measles vaccination coverage among children, few studies ...

View details

Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis.

Publication Type: Academic Journal

Source(s): Journal of hepatology [J Hepatol] 2022 Nov; Vol. 77 (5), pp. 1349-1358. Date of Electronic Publication: 2022 Sep 28.

Abstract: Background & Aims: Cirrhosis is associated with immune dysregulation and hyporesponsiveness to several vaccines including those against COVID-19. Our aim was to compare outcomes between patients with cirrhosis who received 3 doses of either the Pfizer ...

View details

Insights From Studies of the Genetics, Pathogenesis, and Immunogenicity of the Varicella Vaccine.

Publication Type: Academic Journal

Source(s): The Journal of infectious diseases [J Infect Dis] 2022 Oct 21; Vol. 226 (Supplement_4), pp. S385-S391.

Authors:

Abstract: While the varicella vaccine was created with approaches established for other live attenuated viral vaccines, novel methods to probe virus-host interactions have been used to explore the genetics, pathogenesis, and immunogenicity of the vaccine compare...

View details
sponsored